Showing results (101-110 of 498) with videos related to

Sort By:
Pageof 50
Journal of Magnetic Resonance Imaging : JMRI|November 1, 2017
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at stagingChiara Giraudo, Georgios Karanikas, Michael Weber, et al.
Frontiers in Medicine|June 20, 2024
A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines AgencyIvana Silva, Giulia Gabrielli, Juan Garcia Burgos, et al.
Leukemia Research|June 17, 2008
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Francesca Mauro, et al.
Oncoimmunology|March 5, 2016
Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemiaAnna Martner, Anna Rydström, Rebecca E Riise, et al.
Frontiers in Oncology|January 24, 2022
Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaMassimiliano Bonifacio, Cristina Papayannidis, Federico Lussana, et al.
Expert Review of Hematology|November 1, 2016
Management of elderly and unfit patients with chronic lymphocytic leukemiaFrancesca R Mauro, Adriano Salaroli, Maria D Caputo, et al.
International Journal of Hematology|July 4, 2012
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myelomaAsher A Chanan-Khan, Sagar Lonial, Donna Weber, et al.
Leukemia & Lymphoma|March 16, 2021
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experienceSara Pepe, Emilia Scalzulli, Gioia Colafigli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemiaLuciana Teofili, Fiorina Giona, Maurizio Martini, et al.
Haematologica|July 26, 2007
FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximabEmanuela Carlotti, Giuseppe A Palumbo, Elena Oldani, et al.
Pageof 50